Reply : Understanding survival comparisons in non-randomized treatment comparisons for patients with early-stage HCC

Andrew M Moon^{1

2}, Ted K Yanagihara^{2

3}, Joel E Tepper^{2

3}, David A Gerber^{2

4}

Affiliations

¹ Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
³ Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
⁴ Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.

Comment

Andrew M Moon et al. Hepatol Commun. 2023.

. 2023 Sep 15;7(10):e0282.

doi: 10.1097/HC9.0000000000000282. eCollection 2023 Oct 1.

Andrew M Moon^{1

2}, Ted K Yanagihara^{2

3}, Joel E Tepper^{2

3}, David A Gerber^{2

4}

¹ Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina, USA.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA.
³ Department of Radiation Oncology, University of North Carolina, Chapel Hill, North Carolina, USA.
⁴ Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.

No abstract available

Conflict of interest statement

Andrew M. Moon is a consultant for TARGET RWE. David A. Gerber is a consultant for Medtronic.

Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study.
Moon AM, Kim HP, Singal AG, Owen D, Mendiratta-Lala M, Parikh ND, Rose SC, McGinty KA, Agala CB, Burke LM, Abate A, Altun E, Beyer C, Do J, Folkert MR, Forbes C, Hattangadi-Gluth JA, Hayashi PH, Jones K, Khatri G, Kono Y, Lawrence TS, Maurino C, Mauro DM, Mayo CS, Pak T, Patil P, Sanders EC, Simpson DR, Tepper JE, Thapa D, Yanagihara TK, Wang K, Gerber DA. Moon AM, et al. Hepatol Commun. 2023 Jun 14;7(7):e00184. doi: 10.1097/HC9.0000000000000184. eCollection 2023 Jul 1. Hepatol Commun. 2023. PMID: 37314737 Free PMC article.

1. Khosla D, Singh G, Kappor R. Understanding survival comparisons in non-randomized treatment comparisons for patients with early stage HCC. Hepatol Commun. 2023. - PMC - PubMed
1. Moon AM, Kim HP, Singal AG, Owen D, Mendiratta-Lala M, Parikh ND, et al. . Thermal ablation compared to stereotactic body radiation therapy for hepatocellular carcinoma: A multicenter retrospective comparative study. Hepatol Commun. 2023;7:e00184. - PMC - PubMed
1. Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, et al. . AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology. 2023. doi:10.1097/HEP.0000000000000466 - DOI - PMC - PubMed